À Propos de l'Entreprise
- Raison sociale: Beijing Kawin Technology Share-Holding Co.,Ltd
- Pays d'enregistrement: China
- Adresse: No.6 Rongjing East Street, BDA, Beijing, China, Beijing
- Nombre d'employés: 500 - 999
Description:
Focused on viral and immune diseases, Kawin offers mature products built on its specialty in interferon strain management to EP standards, and provides product licensing opportunities including a portfolio of glycyrrhizin products used in dermatology and hepatology, with transfer of interferon and G-CSF (both conventional and pegylated) open to discussion.
Activités Commerciales
Produits Biopharmaceutiques
Fabricant de Principes Actifs (API)
Services Biopharmaceutiques
Fabricant de Principes Actifs (API)
Classification ATC (Anatomique, Thérapeutique, Chimique)
Fabricant de Principes Actifs (API)
Marchés de Vente
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain
Produits/Services Clés
Nos Produits & Services
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire